Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: Pharmacokinetics, clinical outcome, and comparison of formulations

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 1985-1993

  Kohn, E C ^a   Figg, W D ^a   Sarosy, G A ^a   Bauer, K S ^a   Davis, P A ^a   Soltis, M J ^a   Thompkins, A ^a   Liotta, L A ^a   Reed, E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; ENCAPSULATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; POWDER; PRIORITY JOURNAL; SARCOMA; SOLID TUMOR; UROGENITAL TRACT CANCER;

EID: 0030991528     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.1985     Document Type: Article

References (22)

1. Berridge MJ: Calcium signalling and cell proliferation. Bioessays 17:491-500, 1995
2. Cole KA, Kohn EC: Calcium-mediated signal transduction: Biology, biochemistry, and therapy. Cancer Met Rev 13:33-41, 1994
3. Felder CC, Singer-Lahat D, Mathes C: Voltage-independent calcium channels. Regulation by receptors and intracellular calcium stores. Biochem Pharmacol 48:1997-2004, 1994
4. Kohn EC, Liotta LA: L651582, a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 82:54-60, 1990
5. Kohn EC, Sandeen MA, Liotta LA: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52:3208-3212, 1992
6. Kohn EC, Alessandro R, Spoonster J, et al: Angiogenesis: Role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92:1307-1311, 1995
7. Felder CC, Ma AL, Liotta LA, et al: The antiproliferative and antimetastatic compound L651582, inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharm Exp Ther 257:967-971, 1991
8. Gusovsky F, Lueders JE, Kohn EC, et al: Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma: Alternative mechanism for cholinergic receptor-induced phosphoinositide breakdown. J Biol Chem 268:7768-7772, 1993
9. Hupe DJ, Boltz R, Cohen CJ, et al: The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582. J Biol Chem 266:10136-10142, 1991
10. Kohn EC, Felder CC, Jacobs W, et al: Stucture function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res 54:935-942, 1994
11. Alessandro R, Masiero L, Liotta LA, et al: The role of calcium in the regulation of invasion and angiogenesis in vivo. 10:153-160, 1996
12. Kohn EC, Reed E, Sarosy E, et al: Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res 56:569-573, 1996
13. Figg WD, Cole KA, Reed E, et al: Pharmacokinetics of orally administered carboxyamidotriazole (CAI), an inhibitor of calcium-mediated signal transduction. Clin Cancer Res 1:797-803, 1995
14. D'Argenia DZ, Schumitzky A: A program package for simulation and parameter estimation in pharmacokinetic systems. Comp Prog Biomed 9:115-134, 1979
15. Yamaoka K, Nakagawa J, Uno T: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biop 2:165-175, 1978
16. Gibaldi M, Perrier D: Pharmacokinetics. New York, NY, Dekker, 1982
17. Astrow AB: Commentary: Rethinking cancer. Lancet 343: 494-495, 1994
18. Gibbs JB, Oliff A: Pharmaceutical research in molecular oncology. Cell 79:193-198, 1994
19. Schipper H, Goh CR, Wang TL: Shifting the cancer paradigm: Must we kill to cure? J Clin Oncol 13:801-807, 1995
20. Kohn EC, Jacobs W, Kim YS, et al: Calcium influx modulates expression of matrix metalloproteinase-2 (72 kDa type IV collagenase, gelatinase A) expression. J Biol Chem 269:21505-21511, 1994
21. Kohn EC, Liotta LA: Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55:1856-1862, 1995
22. Wasilenko WJ, Palad AJ, Somers KD, et al: Signal transduction therapy for prostate cancer: Sensitivities of human prostate tumor cell lines to the calcium influx inhibitor carboxyamido-triazole. Int J Cancer 68:259-264, 1996